Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild-Moderate Alzheimer's Disease”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00742417
What this trial is testing

Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid

Who this might be right for
Alzheimer's Disease
Instituto Grifols, S.A. 42
Very early researchStudy completedNCT01024660
What this trial is testing

The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

Who this might be right for
Alzheimer's Disease
AstraZeneca 155
Early research (Phase 1)Study completedNCT00733642
What this trial is testing

Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 15
Testing effectiveness (Phase 2)UnknownNCT06096090
What this trial is testing

Phase II Clinical Trial of Interleukin-2 in AD

Who this might be right for
Alzheimer Disease
The Methodist Hospital Research Institute 40
Testing effectiveness (Phase 2)Ended earlyNCT05602727
What this trial is testing

Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 99
Not applicableStudy completedNCT02205710
What this trial is testing

Adaptive Cognitive Training in Healthy Older Adults

Who this might be right for
Mild Cognitive ImpairmentMild to Moderate DementiaAlzheimer's Disease
Bruyère Health Research Institute. 99
Testing effectiveness (Phase 2)Looking for participantsNCT07457125
What this trial is testing

The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
Xuanwu Hospital, Beijing 33
Early research (Phase 1)Study completedNCT02127476
What this trial is testing

Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Kyowa Kirin Co., Ltd. 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT06427668
What this trial is testing

Study of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Spinogenix 24
Testing effectiveness (Phase 2)WithdrawnNCT02246075
What this trial is testing

Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine

Who this might be right for
Alzheimer's DiseaseDementiaCognition
FORUM Pharmaceuticals Inc
Not applicableUnknownNCT04203121
What this trial is testing

The Safety and Scientific Validity of Low-dose Whole Brain Radiotherapy in Alzheimer's Disease.

Who this might be right for
Alzheimer Disease
Kyung Hee University Hospital at Gangdong 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT07191028
What this trial is testing

Alzheimer's Disease THErapy With NEuroaid II

Who this might be right for
Alzheimer's Disease Dementia
Moleac Pte Ltd. 350
Testing effectiveness (Phase 2)Study completedNCT00515333
What this trial is testing

TRx0014 in Patients With Mild or Moderate Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer Type
TauRx Therapeutics Ltd 323
Testing effectiveness (Phase 2)Study completedNCT00955409
What this trial is testing

Long Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 160
Not applicableStudy completedNCT01380288
What this trial is testing

Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine

Who this might be right for
Alzheimer's Disease
Dong-A University 300
Testing effectiveness (Phase 2)Study completedNCT00257673
What this trial is testing

Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Memory Pharmaceuticals 183
Early research (Phase 1)Study completedNCT00633841
What this trial is testing

Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Affiris AG 24
Early research (Phase 1)UnknownNCT04500847
What this trial is testing

Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD

Who this might be right for
Alzheimer Disease, Early OnsetMild Cognitive ImpairmentModerate Dementia
Butler Hospital 35
Testing effectiveness (Phase 2)Study completedNCT01284387
What this trial is testing

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 126
Testing effectiveness (Phase 2)Study completedNCT00880412
What this trial is testing

Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Exonhit 197
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation